Vivalyx is committed to saving the lives of organ failure patients by boosting the vitality and number of donor organs.
Vivalyx has raised $6.3M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Vivalyx's investors include TechVision Fund, Brightlands Venture Partners, Mario Götze, EIC Accelerator, Arve Capital.
Vivalyx is headquartered in Aachen, Germany.
Vivalyx is committed to saving the lives of organ failure patients by boosting the vitality and number of donor organs.
Vivalyx is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vivalyx — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/vivalyx. Accessed August 16, 2026.
VCBacked. (2025). Vivalyx — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/vivalyx
{{cite web |title=Vivalyx — Funding & Investors |url=https://www.vcbacked.co/company/vivalyx |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated